Edition:
India

Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

674.85INR
3:55pm IST
Change (% chg)

Rs-0.55 (-0.08%)
Prev Close
Rs675.40
Open
Rs674.95
Day's High
Rs684.80
Day's Low
Rs671.75
Volume
385,297
Avg. Vol
463,828
52-wk High
Rs879.75
52-wk Low
Rs572.40

SUN.BO

Chart for SUN.BO

About

Sun Pharmaceutical Industries Limited is a pharmaceuticals company. The Company's business segments include US Business, Indian Branded Generics Business, Emerging Markets, Global Consumer Healthcare Business and Active Pharmaceutical Ingredients (API). Its Rest of World segment includes Western Europe, Canada, Australia, New... (more)

Overall

Beta: 0.28
Market Cap(Mil.): Rs1,618,442.00
Shares Outstanding(Mil.): 2,399.29
Dividend: 1.00
Yield (%): 0.15

Financials

  SUN.BO Industry Sector
P/E (TTM): 21.84 28.84 29.63
EPS (TTM): 30.89 -- --
ROI: -- 13.44 12.96
ROE: -- 14.34 14.11

BRIEF-Sun Pharmaceutical Industries says European Medicines Agency approves Tobramycin

* Sun Pharmaceutical Industries clarifies on news item "UK regulator approves Sun Pharma generic drug of Tobramycin"

16 Feb 2017

MEDIA-Sun Pharma's Halol facility to stop making key drugs - Business Standard

- Note: Reuters has not verified this story and does not vouch for its accuracy

16 Feb 2017

Sensex ends at 2-week low; Tata Motors plunges

Indian shares ended at their lowest in two weeks on Wednesday, with Tata Motors pulling the indexes down after posting disappointing results.

15 Feb 2017

Indian shares down; Tata Motors, Sun Pharma drag

Feb 15 Indian shares fell on Wednesday, with Tata Motors and Sun Pharmaceutical Industries weighing on the indexes after posting disappointing results.

15 Feb 2017

BUZZ-India's Sun Pharma hits near 2-week low on Q3 results; Goldman Sachs cuts PT

** Sun Pharmaceutical Industries Ltd falls as much as 3.4 pct, lowest since Feb 2

15 Feb 2017

Morning News Call - India, February 15

To access the newsletter, click on the link: http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_02152017.pdf If you would like to receive this newsletter via email, please register at: https://forms.thomsonreuters.com/india-morning/ FACTORS TO WATCH 10:00 am: Power Minister Piyush Goyal and Mines Secretary Balvinder Kumar at national conclave on mines and minerals 2017 in New Delhi. 11:30 am: India Ratings briefs media on macroeconomic

15 Feb 2017

Sun Pharma's profits drop as U.S. sales hit by pricing, supply issues

MUMBAI Sun Pharmaceutical Industries, India's largest drugmaker, reported its first fall in quarterly profits in a year on Tuesday, as pricing issues and supply constraints affected sales in the United States, its largest market.

14 Feb 2017

UPDATE 2-Sun Pharma's profits drop as U.S. sales hit by pricing, supply issues

* Q3 U.S. sales up 4 pct, India sales up 5 pct (Adds CEO's comments made in conference call with analysts)

14 Feb 2017

BRIEF-Sun Pharmaceutical Industries exec says co expects to be able to address Halol issues over next few qtrs

* Exec says expects to be able to address Halol issues over the next few quarters

14 Feb 2017

India's Sun Pharma Q3 profit falls nearly 5 pct; below estimates

MUMBAI, Feb 14 India's largest drugmaker Sun Pharmaceutical Industries Ltd's third-quarter profit fell below analysts' estimates due to slower sales in the United States, its largest market.

14 Feb 2017

More From Around the Web

Earnings vs. Estimates